Clostridium Butyricum Effects on Gut Health and Microbiota

Clostridium butyricum is a spore-forming, obligate anaerobe naturally present in the gastrointestinal tract of humans and animals. As a butyrate-producing probiotic, it contributes to intestinal homeostasis through multiple mechanisms: enhancing the integrity of the mucosal barrier, modulating local and systemic immune responses, and shaping the composition and metabolic output of the gut microbiota. Its ability to ferment dietary fibres into short-chain fatty acids, particularly butyrate, supports epithelial energy supply, tight-junction protein expression and anti-inflammatory signalling. Beyond its role in inflammatory bowel disorders, C. butyricum has shown promise in regulating lipid metabolism, reducing adiposity, and even enhancing chemotherapeutic efficacy in colorectal cancer models. Its application spans clinical nutrition, animal husbandry and therapeutic adjuvants, reflecting growing recognition of its global significance for metabolic health, immune resilience and microbe-host symbiosis.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Clostridium Butyricum Effects on Gut Health and Microbiota publication trend

The graph below shows the total number of articles in clostridium butyricum effects on gut health and microbiota across all publications each year (not limited to Nature Index journals).

Technical terms

Short-chain fatty acids (SCFAs): Metabolic products of bacterial fermentation of dietary fibres, including butyrate, propionate and acetate, that support epithelial health and immune regulation.

Carbohydrate-active enzymes (CAZymes): A class of microbial enzymes that degrade, modify or synthesise glycosidic bonds; critical for polysaccharide utilisation and host energy harvest.

Extracellular vesicles (EVs): Nano-sized particles released by bacteria carrying proteins, lipids and nucleic acids that facilitate inter-microbial and host–microbe communication.

Mucosal barrier: The epithelial layer of the intestine with tight junctions and mucus that prevents translocation of pathogens and toxins.

References

1. Clostridium butyricum and carbohydrate active enzymes contribute to the reduced fat deposition in pigs. iMeta (2024).
2. Solid-State Fermentation of Wheat Bran with Clostridium butyricum: Impact on Microstructure, Nutrient Release, Antioxidant Capacity, and Alleviation of Ulcerative Colitis in Mice. Antioxidants (2024).
3. Clostridium butyricum and Its Derived Extracellular Vesicles Modulate Gut Homeostasis and Ameliorate Acute Experimental Colitis. Microbiology Spectrum (2022).
4. Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer. Gut Microbes (2023).